Brian Traver

Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial

Andrew P. Ambrosy, Peter S. Pang, Sadiya S. Khan et al. · European Heart Journal · 2013 · 572 citations · Full text

Medicine, Cardiology, Internal Medicine +10

Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: Results from efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan (EVEREST) program

Christopher M. O’Connor, Alan B. Miller, John E. Blair et al. · American Heart Journal · 2010 · 235 citations

Medicine, Cardiology, Pharmacotherapy +11

Continental Differences in Clinical Characteristics, Management, and Outcomes in Patients Hospitalized With Worsening Heart Failure

John E. Blair, Faı̈ez Zannad, Marvin A. Konstam et al. · Journal of the American College of Cardiology · 2008 · 175 citations

Medicine, Cardiology, Internal Medicine +15

Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial

J. E. A. Blair, Peter S. Pang, Robert W. Schrier et al. · European Heart Journal · 2011 · 133 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

A comprehensive, longitudinal description of the in-hospital and post-discharge clinical, laboratory, and neurohormonal course of patients with heart failure who die or are re-hospitalized within 90 days: analysis from the EVEREST trial

Mihai Gheorghiade, Peter S. Pang, Andrew P. Ambrosy et al. · Heart Failure Reviews · 2011 · 121 citations

Medicine, Cardiology, Internal Medicine +12